Rubicon Research

Not Rated
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
637.00
13 (2.08%)
BSENSE

Dec 05

BSE+NSE Vol: 6.05 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 116.99% vs -1.63% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 736.00% vs -53.86% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 64.87% vs 110.10% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 638.92% vs -201.23% in Mar 2023

Compare Profit and Loss Results of Rubicon Research
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
853.00
724.00
129.00
17.82%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
853.00
724.00
129.00
17.82%
Expenditure (Ex Depriciation)
Stock Adjustments
-53.00
16.00
-69.00
-431.25%
Raw Materials Consumed
336.00
169.00
167.00
98.82%
Power & Fuel Cost
18.00
0.00
18.00
0%
Employee Cost
125.00
102.00
23.00
22.55%
Operating Expenses
41.00
44.00
-3.00
-6.82%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
91.00
57.00
34.00
59.65%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
16.00
-5.00
-31.25%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
699.00
453.00
246.00
54.30%
Operating Profit (PBDIT) excl Other Income
154.00
270.00
-116.00
-42.96%
Other Income
18.00
13.00
5.00
38.46%
Operating Profit (PBDIT)
173.00
283.00
-110.00
-38.87%
Interest
31.00
3.00
28.00
933.33%
Profit before Depriciation and Tax
141.00
279.00
-138.00
-49.46%
Depreciation
38.00
4.00
34.00
850.00%
Profit Before Taxation & Exceptional Items
102.00
275.00
-173.00
-62.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
102.00
246.00
-144.00
-58.54%
Provision for Tax
11.00
65.00
-54.00
-83.08%
Profit After Tax
91.00
181.00
-90.00
-49.72%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
25.00
164.00
-139.00
-84.76%
Profit Available for appropriations
116.00
345.00
-229.00
-66.38%
Appropriations
116.00
345.00
-229.00
-66.38%
Equity Dividend (%)
2%
550%
-548.00
Earnings Per Share
5.98
78.59
-72.61
-92.39%
Profit And Loss - Net Sales
Net Sales 853.89 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 116.99% vs -1.63% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 154.59 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 736.00% vs -53.86% in Mar 2023

Profit And Loss - Interest
Interest 31.26 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 64.87% vs 110.10% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 91.01 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 638.92% vs -201.23% in Mar 2023